Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R01 AG055401
NIA NIH HHS
Grant: R01 AG062277
NIA NIH HHS
Grant: P30 AG043073
NIA NIH HHS
Grant: P30 AG066589
National Institutes of Health
Grant: 3R01AG055401-02S2
Reducing Racial and Ethnic Disparities in Alzheimer's Disease: Role of ACOs
National Institutes of Health
Grant: 3P30AG043073-07S1
The Science of Alzheimer's Disease and Related Dementias
National Institutes of Health
Grant: 5P30AG066589-02
Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
Fields of Study
MeSH Terms
Keywords